Cystatin-SA/SN are cysteine protease inhibitors that enhance eosinophil activation and recruitment through induction of IL-5 and suppress allergic rhinitis symptoms by inhibiting allergenic protease activities and protecting the nasal tight junction barrier in an allergen-specific manner (71, 72). Here, IL5 is linked to allergic rhinitis.